Market Share of Influenza Medications Industry
In Influenza Medications market major players are focused on expanding their business in different areas by adopting various market strategies such as partnerships, collaborations, acquisitions and mergers etc. Key developments in the market include US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Roche's XofluzaTM (baloxavir marboxil) for the Medications of acute, uncomplicated influenza, or flu in OCT 2019.
Influenza Medications Market Leaders
Sanofi
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.(Genentech USA, Inc.)
Seqirus
NATCO Pharma Limited
*Disclaimer: Major Players sorted in no particular order
